Endoglin (CD105) and vascular endothelial growth factor (VEGF) as prognostic markers in prostatic adenocarcinoma

被引：0
|
作者：
El-Gohary, YM [1 ]
Saad, RS [1 ]
Tung, M [1 ]
Olson, PR [1 ]
Cohen, JK [1 ]
Miller, R [1 ]
Liu, YL [1 ]
Silverman, JF [1 ]
机构：
[1] Allegheny Gen Hosp, Pittsburgh, PA 15212 USA
来源：
MODERN PATHOLOGY | 2005年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
637
引用
收藏
页码：138A / 139A
页数：2
相关论文
共 50 条
  • [1] Endoglin (CD105) and vascular endothelial growth factor (VEGF) as prognostic markers in prostatic adenocarcinoma
    El-Gohary, YM
    Saad, RS
    Tung, M
    Olson, PR
    Cohen, JK
    Miller, R
    Liu, YL
    Silverman, JF
    LABORATORY INVESTIGATION, 2005, 85 : 138A - 139A
  • [2] Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in prostatic adenocarcinoma
    El-Gohary, Yasser M.
    Silverman, Jan F.
    Olson, Peter R.
    Liu, Yulin L.
    Cohen, Jeffrey K.
    Miller, Ralph
    Saad, Reda S.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2007, 127 (04) : 572 - 579
  • [3] Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in esophageal adenocarcinoma
    Saad, RS
    El-Gohary, Y
    Memari, E
    Liu, YL
    Silverman, JF
    HUMAN PATHOLOGY, 2005, 36 (09) : 955 - 961
  • [4] Endoglin (CD105) and vascular endothelial growth factor (VEGF) as prognostic markers in colon cancer
    Saad, RS
    Liu, YL
    Nathan, G
    Celebrezze, J
    Medich, D
    Tung, MY
    Silverman, JF
    MODERN PATHOLOGY, 2003, 16 (01) : 132A - 132A
  • [5] Endoglin (CD105) and vascular endothelial growth factor (VEGF) as prognostic markers in colon cancer
    Saad, RS
    Liu, YL
    Nathan, G
    Celebrezze, J
    Medich, D
    Tung, MY
    Silverman, JF
    LABORATORY INVESTIGATION, 2003, 83 (01) : 132A - 132A
  • [6] Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer
    Saad, RS
    Liu, YLL
    Nathan, G
    Celebrezze, J
    Medich, D
    Silverman, JF
    MODERN PATHOLOGY, 2004, 17 (02) : 197 - 203
  • [7] CD105 (Endoglin) as negative prognostic factor in AML
    Joseph Kauer
    Karolin Schwartz
    Claudia Tandler
    Clemens Hinterleitner
    Malte Roerden
    Gundram Jung
    Helmut R. Salih
    Jonas S. Heitmann
    Melanie Märklin
    Scientific Reports, 9
  • [8] CD105 (Endoglin) as negative prognostic factor in AML
    Kauer, Joseph
    Schwartz, Karolin
    Tandler, Claudia
    Hinterleitner, Clemens
    Roerden, Malte
    Jung, Gundram
    Salih, Helmut R.
    Heitmann, Jonas S.
    Maerklin, Melanie
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [9] Prognostic Significance of Endoglin (CD105) as an Angiogenic Marker in Endocervical Adenocarcinoma
    Cullen, E.
    Silverman, J. F.
    Khalifa, M. A.
    Ismiil, N.
    Dube, V.
    Nofech-Mozes, S.
    Ghorab, Z.
    Saad, R. S.
    LABORATORY INVESTIGATION, 2010, 90 : 239A - 239A
  • [10] Prognostic Significance of Endoglin (CD105) as an Angiogenic Marker in Endocervical Adenocarcinoma
    Cullen, E.
    Silverman, J. F.
    Khalifa, M. A.
    Ismiil, N.
    Dube, V.
    Nofech-Mozes, S.
    Ghorab, Z.
    Saad, R. S.
    MODERN PATHOLOGY, 2010, 23 : 239A - 239A
12345